Streetbeat News

Stock Prices

OSS

One Stop Systems (NASDAQ:OSS) is expected to report a quarterly EPS of $-0.04 on March 21, 2024. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. Historical data shows that OSS's stock price reacts to both earnings performance and guidance. Last quarter, OSS beat the EPS estimate by $0.02, resulting in a 2.03% stock price increase the following day. Over the last year, OSS shares have increased by 31.4%, trading at $3.64 as of March 19.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 4:01 pm

PLTR

Palantir Technologies (PLTR) is evaluated against its competitors in the Software industry, showing a premium valuation with high PE, PB, and PS ratios but lower efficiency metrics like ROE, EBITDA, and gross profit. Despite this, PLTR's revenue growth outperforms the industry average, indicating strong sales performance.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 4:00 pm

DLO

DLocal (NASDAQ:DLO) has received mixed analyst ratings over the past three months, with 4 analysts offering insights. The sentiment has shifted slightly positive with 2 bullish and 2 somewhat bullish ratings recently. The average 12-month price target is now $21.00, down from $23.00, indicating a potential downside. Financial performance highlights include a revenue growth rate of 46.54%, a net margin of 24.59%, and an ROE of 9.84%, positioning DLocal strongly in its sector.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 4:00 pm

RMTI

Rockwell Medical (NASDAQ:RMTI) is scheduled to release its quarterly earnings report on March 21, 2024. Analysts predict an EPS of $-0.07. The company's past performance shows a mixed reaction to earnings reports, with the last quarter resulting in a 12.76% share price increase following an EPS beat. Shares are currently trading at $1.41, up 17.39% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 4:00 pm

UBER

The analysis compares Uber Technologies (NYSE:UBER) against its competitors in the Ground Transportation industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Uber shows a premium valuation with higher ratios compared to the industry average but also demonstrates strong operational performance and growth prospects with its high ROE, EBITDA, gross profit, and revenue growth.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 4:00 pm

TMUS

In the last three months, 10 analysts have updated their ratings on T-Mobile US (TMUS), showing a predominantly bullish outlook with an average 12-month price target of $184.9, reflecting a 1.28% increase from the previous target. The company's financial performance indicates strong market recognition, revenue growth, and profitability, with a notable presence in the U.S. wireless and fixed-wireless broadband markets.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 4:00 pm

CRM

An industry comparison of Salesforce (CRM) against its competitors in the Software industry reveals potential undervaluation based on PE, PB, and PS ratios. Despite a lower ROE indicating possible inefficiency, Salesforce's high EBITDA and gross profit suggest strong operational performance. However, its revenue growth is below the industry average, raising concerns about future prospects. The company's lower debt-to-equity ratio compared to top peers indicates a favorable financial position.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 4:00 pm

EQIX

Hindenburg Research has published a short report on Equinix Inc (NASDAQ:EQIX), alleging inflated profitability metrics and an 'AI pipe dream.' Equinix's stock fell up to 7% before recovering slightly to a 4.5% loss. The report claims Equinix manipulated its AFFO through accounting tricks, boosting it by $3 billion since 2015, while insiders sold over $327 million in stock. Equinix is investigating the claims.

Portfolio Pulse from Adam Eckert

March 20, 2024 | 3:52 pm

MRNA

Moderna Inc (NASDAQ:MRNA) shares fell by 2.7% to $102.25, likely in response to BioNTech's disappointing fourth-quarter earnings. BioNTech's lower-than-expected earnings and sales have raised concerns among investors about Moderna's future performance, given the direct competition between the two in the mRNA space. Despite this, Wall Street analysts generally rate Moderna as Outperform, with expectations of a stock rise in the coming year.

Portfolio Pulse from Henry Khederian

March 20, 2024 | 3:49 pm

OLLI

Ollie's Bargain Outlet Holdings Inc (NASDAQ:OLLI) reported mixed Q4 FY23 earnings with an 18% sales growth to $648.9 million, slightly missing analyst expectations. Comparable store sales rose 3.9%, and gross profit increased by 27.4% to $263 million. Operating income surged 44.3% to $97.7 million. The company ended the year with $353.2 million in cash and equivalents. Adjusted EPS of $1.23 beat estimates, but the FY24 outlook for sales and EPS is below consensus expectations, leading to a 0.70% drop in OLLI shares to $74.82.

Portfolio Pulse from Shivani Kumaresan

March 20, 2024 | 3:49 pm